BiVictriX Therapeutics plc (AIM: BVX)
10.00
+1.50 (17.65%)
Sep 10, 2024, 6:29 PM GMT+1
BiVictriX Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 1.69 | 3.28 | 3.29 | 6.06 | 0.86 | 0.13 | Upgrade
|
Cash & Short-Term Investments | 1.69 | 3.28 | 3.29 | 6.06 | 0.86 | 0.13 | Upgrade
|
Cash Growth | -11.29% | -0.24% | -45.79% | 603.36% | 568.22% | -38.86% | Upgrade
|
Other Receivables | 0.9 | 0.45 | 0.57 | 0.26 | 0.14 | 0.13 | Upgrade
|
Receivables | 0.9 | 0.45 | 0.57 | 0.26 | 0.14 | 0.13 | Upgrade
|
Prepaid Expenses | - | 0.09 | 0.11 | 0.22 | 0.01 | 0 | Upgrade
|
Total Current Assets | 2.59 | 3.82 | 3.97 | 6.54 | 1.01 | 0.27 | Upgrade
|
Property, Plant & Equipment | 0.39 | 0.48 | 0.57 | 0.34 | 0.06 | 0 | Upgrade
|
Total Assets | 2.98 | 4.3 | 4.54 | 6.88 | 1.07 | 0.27 | Upgrade
|
Accounts Payable | 0.47 | 0.21 | 0.11 | 0.07 | 0.26 | 0.03 | Upgrade
|
Accrued Expenses | - | 0.25 | 0.13 | 0.17 | 0.06 | 0.04 | Upgrade
|
Current Portion of Leases | 0.12 | 0.13 | 0.11 | 0.07 | - | - | Upgrade
|
Current Income Taxes Payable | - | 0.04 | 0.04 | 0.07 | 0.01 | 0.02 | Upgrade
|
Total Current Liabilities | 0.59 | 0.62 | 0.39 | 0.38 | 0.33 | 0.09 | Upgrade
|
Long-Term Debt | - | - | - | - | 0.67 | - | Upgrade
|
Long-Term Leases | 0.09 | 0.13 | 0.19 | 0.18 | - | - | Upgrade
|
Total Liabilities | 0.68 | 0.76 | 0.58 | 0.55 | 1 | 0.09 | Upgrade
|
Common Stock | 0.83 | 0.83 | 0.66 | 0.66 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 13.94 | 13.94 | 12.05 | 12.05 | 1.43 | 1.27 | Upgrade
|
Retained Earnings | -10.1 | -8.89 | -6.35 | -3.85 | -1.52 | -1.09 | Upgrade
|
Comprensive Income & Other | -2.36 | -2.34 | -2.41 | -2.54 | 0.16 | 0.01 | Upgrade
|
Shareholders' Equity | 2.31 | 3.54 | 3.96 | 6.33 | 0.07 | 0.18 | Upgrade
|
Total Liabilities & Equity | 2.98 | 4.3 | 4.54 | 6.88 | 1.07 | 0.27 | Upgrade
|
Total Debt | 0.2 | 0.26 | 0.3 | 0.25 | 0.67 | - | Upgrade
|
Net Cash (Debt) | 1.49 | 3.02 | 2.99 | 5.82 | 0.19 | 0.13 | Upgrade
|
Net Cash Growth | -0.47% | 0.84% | -48.56% | 2945.55% | 48.06% | -38.86% | Upgrade
|
Net Cash Per Share | 0.02 | 0.04 | 0.05 | 0.15 | 0.01 | 1.35 | Upgrade
|
Filing Date Shares Outstanding | 82.53 | 82.53 | 66.12 | 66.12 | 28.62 | 0.1 | Upgrade
|
Total Common Shares Outstanding | 82.53 | 82.53 | 66.12 | 66.12 | 28.62 | 0.1 | Upgrade
|
Working Capital | 2 | 3.2 | 3.57 | 6.16 | 0.68 | 0.18 | Upgrade
|
Book Value Per Share | 0.03 | 0.04 | 0.06 | 0.10 | 0.00 | 1.88 | Upgrade
|
Tangible Book Value | 2.31 | 3.54 | 3.96 | 6.33 | 0.07 | 0.18 | Upgrade
|
Tangible Book Value Per Share | 0.03 | 0.04 | 0.06 | 0.10 | 0.00 | 1.88 | Upgrade
|
Buildings | - | 0.01 | 0.01 | 0 | 0 | - | Upgrade
|
Machinery | - | 0.34 | 0.34 | 0.11 | 0.06 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.